InfuSystems Holdings Inc (INFU) - Total Liabilities

Latest as of March 2026: $39.91 Million USD

Based on the latest financial reports, InfuSystems Holdings Inc (INFU) has total liabilities worth $39.91 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of InfuSystems Holdings Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.

InfuSystems Holdings Inc - Total Liabilities Trend (2005–2025)

This chart illustrates how InfuSystems Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of InfuSystems Holdings Inc.

InfuSystems Holdings Inc Competitors by Total Liabilities

The table below lists competitors of InfuSystems Holdings Inc ranked by their total liabilities.

Company Country Total Liabilities
Bikurey Hasade Holdings Ltd
TA:BKRY
Israel ILA979.37 Million
Black Spade Acquisition II Co Unit
NASDAQ:BSIIU
USA $6.81 Million
HomeToGo SE
F:HTG
Germany €387.58 Million
GomSpace Group AB
ST:GOMX
Sweden Skr358.66 Million
Halma PLC
LSE:HLMA
UK GBX1.35 Billion
Alarko Carrier Sanayi ve Ticaret AS
IS:ALCAR
Turkey TL3.54 Billion
La Finca Global Assets SOCIMI S.A.
MC:YLFG
Spain €521.85 Million
Oriola-KD Oyj B
HE:OKDBV
Finland €830.90 Million

Liability Composition Analysis (2005–2025)

This chart breaks down InfuSystems Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See INFU net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.14 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.68 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.40 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how InfuSystems Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for InfuSystems Holdings Inc (2005–2025)

The table below shows the annual total liabilities of InfuSystems Holdings Inc from 2005 to 2025.

Year Total Liabilities Change
2025-12-31 $43.23 Million -6.19%
2024-12-31 $46.09 Million -8.95%
2023-12-31 $50.61 Million -1.50%
2022-12-31 $51.38 Million +4.20%
2021-12-31 $49.31 Million -12.31%
2020-12-31 $56.24 Million -1.14%
2019-12-31 $56.89 Million +30.39%
2018-12-31 $43.63 Million +15.04%
2017-12-31 $37.93 Million -16.92%
2016-12-31 $45.66 Million +1.07%
2015-12-31 $45.17 Million +33.80%
2014-12-31 $33.76 Million -2.57%
2013-12-31 $34.65 Million -7.62%
2012-12-31 $37.51 Million +3.91%
2011-12-31 $36.10 Million -20.17%
2010-12-31 $45.22 Million +36.11%
2009-12-31 $33.23 Million -8.08%
2008-12-31 $36.15 Million -24.17%
2007-12-31 $47.67 Million +35.60%
2006-12-31 $35.15 Million +19532.09%
2005-12-31 $179.05K --

About InfuSystems Holdings Inc

NYSE MKT:INFU USA Medical Devices
Market Cap
$194.96 Million
Market Cap Rank
#17388 Global
#4078 in USA
Share Price
$9.66
Change (1 day)
-2.82%
52-Week Range
$7.42 - $10.79
All Time High
$22.92
About

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment … Read more